Genpharmasec (BOM:531592) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 30, 2026)


BOM:531592 Genpharmasec Ltd BOM:531592
57 GF Score
Price ₹1.11
GF Value ₹10.36
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Genpharmasec Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Genpharmasec's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

BOM:531592 vs ZTS, UTHR: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Genpharmasec's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genpharmasec Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genpharmasec's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Genpharmasec's Margin of Safety % (DCF Earnings Based) falls into.


BOM:531592
57GF Score
Genpharmasec Ltd BOM:531592
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Genpharmasec (BOM:531592) Overvalued in 2026?

Based on GuruFocus' analysis, Genpharmasec stock appears to be undervalued. The current stock price of ₹1.11 is trading 89.3% below its estimated GF Value™ of ₹10.36. GuruFocus considers Genpharmasec to be Possible Value Trap.

Key valuation signals for BOM:531592:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹10.36 vs. price of ₹1.11 (89.3% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the BOM:531592 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genpharmasec Business Description

Address Akurli Road, Office No. 104 and 105, 1st Floor, Gundecha Industrial Premises Co-op Soc. Ltd., Kandivali (East), Mumbai, MH, IND, 400101
Genpharmasec Ltd is engaged in pharmaceutical activities and services. The company operates in three reportable segments, namely: Diagnostic Pharma Equipment, Trading in Securities, and Laboratory Testing. The company generates the majority of its revenue from the Diagnostic Pharma Equipment Segment. Geographically, the company generates the majority of its revenue from the Domestic market.
57GF Score

Get the complete analysis for BOM:531592

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1.11
Price
₹10.36
GF Value